Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K‐AKT signaling pathway

BACKGROUND: Epiplakin1 (EPPK1) has been associated with disease progression and unfavorable prognosis of many cancers, but its functional involvement in esophageal squamous cell carcinoma (ESCC) remains to be uncovered. METHODS: The Quantitative Real‐time PCR (qPCR) assay was employed to determine t...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Zhongshi, Dai, Chengcheng, Wang, Zhiqian, Wang, Zifan, Wang, Zheng, Zhang, Tongsong, Niu, Wenjing, Ma, Xuezhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013648/
https://www.ncbi.nlm.nih.gov/pubmed/35238170
http://dx.doi.org/10.1111/1759-7714.14366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013648/
https://www.ncbi.nlm.nih.gov/pubmed/35238170
http://dx.doi.org/10.1111/1759-7714.14366

Ejemplares similares